A Multicenter Prospective Observational Cohort Study Determining the Cost-effectiveness of Extracorporal Life Support (ECLS) Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Critically Ill
- Sponsor
- University Medical Center Groningen
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- health related quality of life
- Last Updated
- 6 years ago
Overview
Brief Summary
This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.
Detailed Description
A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control. Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.
Investigators
Willem Dieperink
research coordinator
University Medical Center Groningen
Eligibility Criteria
Inclusion Criteria
- •Admitted to intensive care
- •Treated with extracorporeal life support
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
health related quality of life
Time Frame: 12 months
health related quality of life with EQ-5D questionnaire at 6 and 12 months